Herman J C Yeh

Title: Herman J C Yeh: Innovator in Nicotinic Acetylcholine Receptor Agonists

Introduction

Herman J C Yeh is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of pharmacology, particularly through his work on nicotinic acetylcholine receptor agonists. With a total of 2 patents, his innovations aim to address various neurological disorders.

Latest Patents

Yeh's latest patents focus on novel nicotinic acetylcholine receptor agonists, including phantasmidine and its derivatives. These compounds are designed to treat disorders that respond to nicotinic acetylcholine receptor agonists, such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction. The methods disclosed in his patents provide new avenues for therapeutic interventions in these challenging conditions.

Career Highlights

Throughout his career, Yeh has worked with esteemed institutions such as Indiana State University and the National Institutes of Health, a component of the US Department of Health & Human Services. His research has contributed to the understanding and treatment of complex neurological disorders.

Collaborations

Yeh has collaborated with notable colleagues, including Richard W Fitch and Thomas F Spande. These partnerships have further enriched his research and innovations in the field.

Conclusion

Herman J C Yeh's work in developing nicotinic acetylcholine receptor agonists represents a significant advancement in the treatment of various neurological disorders. His contributions continue to impact the field of pharmacology and improve patient outcomes.